EMEA-001892-PIP01-15 - paediatric investigation plan

Fluoroestradiol (18F)

Key facts

• Active Substance:
  Fluoroestradiol (18F)
• Therapeutic area:
  Diagnostic
• Decision number:
  P/0055/2016
• PIP number:
  EMEA-001892-PIP01-15
• Pharmaceutical form(s):
  Solution for injection
• Condition(s) / indication(s):
  Detection of increased expression of oestrogen receptors in tissues and organs for diagnostic purposes
• Route(s) of administration:
  Intravenous use
• Contact for public enquiries:

  Florentin Artner

  France; Tel. [phone]; E-mail: [e-mail]

• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  18/03/2016

Decision

P/0082/2016: EMA decision of 18 March 2016 on the agreement of a paediatric investigation plan and on the granting of a waiver for tetracaine (hydrochloride) / oxymetazoline (hydrochloride) (EMEA-001764-PIP03-15)

AdoptedReference Number: EMA/131632/2016